|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-15 EDT
|
5-day change | 1st Jan Change | ||
| 0.8090 SEK | -0.12% |
|
+4.52% | +10.97% |
| 08-25 | Isofol Medical gets a new fair value estimate of 1.70 kronor from Redeye | FW |
| 08-25 | Isofol Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 259M 26.02M 23.22M 21.58M 19.63M 36.94M 2.46B 37.6M 101M 1.29B 97.64M 95.57M 4.11B | P/E 2026 * |
-4.26x | P/E 2027 * | -27x |
|---|---|---|---|---|---|
| Enterprise Value | 259M 26.02M 23.22M 21.58M 19.63M 36.94M 2.46B 37.6M 101M 1.29B 97.64M 95.57M 4.11B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 7.98x |
| Free-Float |
73.93% | Yield 2026 * |
-
| Yield 2027 * | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ISOFOL | Delayed | |
Deutsche Boerse AG
| 5IU | Delayed | |
|
Boerse Muenchen
| 5IU | Real-time |
| 1 day | -0.12% | ||
| 1 week | +4.52% | ||
| Current month | +6.45% | ||
| 1 month | +10.07% | ||
| 3 months | +4.79% | ||
| 6 months | +13.94% | ||
| Current year | +10.97% |
| 1 week | 0.77 |  | 0.83 |
| 1 month | 0.7 | | 0.85 |
| Current year | 0.55 | | 0.99 |
| 1 year | 0.55 | | 0.99 |
| 3 years | 0.45 | | 4.88 |
| 5 years | 0.45 | | 14.44 |
| 10 years | 0.45 | | 33.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Petter Lindqvist
CEO | Chief Executive Officer | 74 | 2024-01-08 |
Margareta Hagman
DFI | Director of Finance/CFO | 60 | 2024-08-12 |
Roger Tell
CEO | Chief Executive Officer | 61 | 2023-06-21 |
| Director | Title | Age | Since |
|---|---|---|---|
Lars Erik Lind
CHM | Chairman | 85 | 2010-06-30 |
| Chairman | 81 | 2011-12-31 | |
Sten Nilsson
BRD | Director/Board Member | 78 | 2024-01-03 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/10/21 | Sell | 58,767 | 0.0364% | |||
| 12/10/21 | Sell | 58,767 | 0.0364% | |||
| 6/14/21 | Others | Chief Financial Officer | 15,153 | 0.0145% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.12% | +4.52% | +7.87% | +14.75% | 25.78M | |
| +3.55% | +7.01% | +51.42% | +105.45% | 1,077B | |
| -0.25% | -1.25% | +32.49% | +61.48% | 612B | |
| +0.59% | +4.03% | +25.28% | +91.54% | 501B | |
| -1.48% | +1.97% | +72.62% | +39.59% | 364B | |
| +2.37% | +7.66% | +33.65% | +48.87% | 353B | |
| +2.64% | +6.95% | +21.01% | +43.85% | 278B | |
| +3.24% | +6.78% | +0.43% | +15.71% | 251B | |
| +1.86% | +6.53% | +45.98% | +52.77% | 230B | |
| +2.49% | +6.98% | +33.03% | +102.67% | 190B | |
| Average | +1.49% | +4.42% | +32.38% | +57.67% | 385.65B | |
| Weighted average by Cap. | +1.74% | +4.12% | +38.65% | +71.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 32.5M 3.26M 2.91M 2.71M 2.46M 4.63M 309M 4.71M 12.72M 161M 12.24M 11.98M 516M |
| Net income | -58.5M -5.87M -5.24M -4.87M -4.43M -8.33M -556M -8.48M -22.89M -290M -22.03M -21.56M -928M | -69.3M -6.95M -6.21M -5.77M -5.25M -9.87M -659M -10.05M -27.11M -344M -26.1M -25.54M -1.1B |
| Net Debt | - | - |
Employees
7
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-15 | SEK 0.8090 | -0.12% | 277,974 |
| 26-10-14 | SEK 0.8100 | -1.22% | 128,078 |
| 26-10-13 | SEK 0.8200 | +4.33% | 479,068 |
| 26-10-12 | SEK 0.7860 | -1.50% | 283,051 |
| 26-10-09 | SEK 0.7980 | +3.10% | 531,163 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ISOFOL Stock
Select your edition
All financial news and data tailored to specific country editions
